Current therapy for hepatitis C: pegylated interferon and ribavirin

Zeuzem, 2001, Peginterferon alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapy, Expert Opin Investig Drugs, 10, 2201, 10.1517/13543784.10.12.2201

McHutchison, 1998, Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group, N Engl J Med, 339, 1485, 10.1056/NEJM199811193392101

Heathcote, 2000, Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis, N Engl J Med, 343, 1673, 10.1056/NEJM200012073432302

Fried, 2002, Combination of peginterferon alfa-2a plus ribavirin in patients with chronic hepatitis C virus infection, N Engl J Med, 347, 975, 10.1056/NEJMoa020047

Ferenci, 2001, Early prediction of response to 40 kDa peginterferon alfa-2a (PEGASYS) plus ribavirin in patients with chronic hepatitis C, Hepatology, 34, 351A

Hadziyannis, 2002, Peginterferon alpha-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examing effect of duration of treatment and RBV dose [abstract], Hepatology, 36, 536

Fried M.W. Side effects of therapy for hepatitis C and their management. Hepatology, in press

Lindsay, 2001, A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C, Hepatology, 34, 395, 10.1053/jhep.2001.26371

Manns, 2001, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C, a randomised trial, Lancet, 358, 958, 10.1016/S0140-6736(01)06102-5

Wong J.B., Davis G.L., McHutchison J.G., Manns M.P., Albrecht J.K. Clinical implications of testing viral response during peginterferon alfa-2b and ribavirin treatment for chronic hepatitis C [abstract]. Hepatology, in press

Poynard, 2002, Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C, Gastroenterology, 122, 1303, 10.1053/gast.2002.33023

Pawlotsky, 2000, Standardization of hepatitis C virus RNA quantification, Hepatology, 32, 654, 10.1053/jhep.2000.16603

McHutchison, 2002, Adherence to combination therapy enhances sustained response in genotype-1 C. infected patients with chronic hepatitis, Gastroenterology, 123, 1061, 10.1053/gast.2002.35950

Wong J.B., McHutchison J., Manns M., Davis G.L., Albrecht J. Effect of treatment management algorithms on peginterferon alfa-2b costs for chronic hepatitis C [abstract]. Hepatology, in press